-

Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the fourth quarter and full-year ended December 31, 2025 on Thursday, March 26, 2026. The Company will issue a press release at 6:00am ET followed by a live webcast at 8:00am ET.

$RMTI to release its Q4/FY'25 financial and operational results on Thursday, March 26, 2026.

Share

WEBCAST DETAILS

Date: Thursday, March 26, 2026

Time: 8:00am ET

Webcast and Replay: www.RockwellMed.com/Results

Speakers:

  • Mark Strobeck, Ph.D. — President and Chief Executive Officer
  • Jesse Neri — SVP, Chief Financial Officer

Format: Discussion of fourth quarter and full-year 2025 financial and operational results followed by Q&A.

ABOUT ROCKWELL MEDICAL

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed in freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work® four years in a row (2023-2026) and named Fortune Best Workplaces in Manufacturing & Production™ in 2024 and 2025, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis Solutions™. For more information, visit www.rockwellmed.com.

Contacts

(248) 432-1362
IR@RockwellMed.com

Rockwell Medical

NASDAQ:RMTI
Details
Headquarters: Wixom, MI
CEO: Mark Strobeck
Employees: 250
Organization: PUB
Revenues: 83,600,000 (2023)

Release Summary
Rockwell Medical will release its results for the fourth quarter and full-year ended December 31, 2025 on Thursday, March 26, 2026.
Release Versions
$Cashtags

Contacts

(248) 432-1362
IR@RockwellMed.com

Social Media Profiles
More News From Rockwell Medical

Rockwell Medical Named 'Great Place to Work' for Fourth Year in a Row

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical has been certified as a Great Place to Work for the fourth year in a row....

Rockwell Medical Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Results

WIXOM, Mich.--(BUSINESS WIRE)--$RMTI announced preliminary unaudited financial results for the three months and twelve months ended December 31, 2025....

Rockwell Medical Adds 30 New Customers in the West

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical is a viable alternative supplier in the western U.S., serving customers with a reliable supply chain and high-quality products....
Back to Newsroom